🚧 Under construction — VoTechWorks is being built. A free tech program — complimentary, as our commitment to get America working.
voTechWorksGrade 13 · a vocational technology learning center, by urbanicity
newSchoolWorks.com › VoTechWorks › Health & Personal Services › Pharmacy Technician › Pharmacy Law, Safety and Quality › Lesson 7
HLT-PHAR41-05 · Lesson 7 · 15 clock hours · theory

Recalls and drug-supply-chain security

Objective. Act on Class I, II and III recalls and explain product serialisation and tracing under the Drug Supply Chain Security Act.

⚠ Pending professional review

This lesson, its worked examples and its practice questions has not yet been verified by a licensed pharmacist or by a certification or approval body. It is a study draft and may contain errors. Do not use it to make decisions about any patient or medication. Always follow your instructor, your supervising professional, and current official references and regulations.

VoTechWorks program approval and accreditation are still in progress. Credentials are issued only by the certifying bodies named in each program, after their own exams.

Recalls and Drug-Supply-Chain Security

When a drug product is found to be unsafe, ineffective, or mislabeled, it must be removed from distribution before it reaches—or continues to harm—patients. As a pharmacy technician, you are often the person who physically pulls recalled products from the shelf, so you must act quickly and correctly every time.

FDA Recall Classifications

The Food and Drug Administration (FDA) assigns every drug recall one of three classes based on the seriousness of the health hazard.

Class I is the most serious. The product is reasonably likely to cause serious adverse health consequences or death. Examples include a drug contaminated with a dangerous pathogen or a product with a fatally incorrect potency. Class I recalls demand immediate action—stop dispensing, pull all affected stock, and notify your pharmacist-in-charge at once.

Class II involves a product that may cause temporary or medically reversible adverse health consequences, or where the probability of serious harm is remote. Action is still urgent, but the immediate danger is lower.

Class III is the least severe. The product is unlikely to cause adverse health consequences, but it violates FDA labeling or manufacturing regulations. Even so, recalled product must still be removed and not dispensed.

Regardless of class, the process is the same: receive the recall notice, search inventory using the lot number and expiration date on the notice, quarantine every affected unit, document what you found and removed, and follow your pharmacy's procedure for returning or disposing of recalled product. Never assume a product is unaffected just because you cannot immediately locate it—check refrigerators, automated dispensing cabinets, and will-call bins as well as open shelves.

Receiving and Acting on a Recall Notice

Recall notices arrive from the FDA MedWatch program, wholesalers, or the manufacturer. Each notice identifies the product name, strength, dosage form, lot number(s), expiration date(s), and the reason for the recall. Read the entire notice before pulling product so you do not miss affected lots or pull unaffected ones.

After pulling recalled stock, place it in a clearly marked quarantine area away from dispensing inventory. Attach the recall notice or a copy to the quarantined product. Complete the pharmacy's recall log and notify the pharmacist-in-charge; he or she will communicate with the wholesaler or manufacturer about returns or credits. Patient notification, when required, is directed by the pharmacist or pharmacy management—this is outside the technician's independent scope.

The Drug Supply Chain Security Act (DSCSA)

The Drug Supply Chain Security Act (DSCSA), enacted as part of federal law, establishes a national, electronic system to track and trace prescription drug products as they move through the supply chain from manufacturer to dispenser. Its goals are to detect and remove counterfeit, stolen, or otherwise illegitimate products before they reach patients.

Product serialization is the foundation of the DSCSA. Every package of a prescription drug must carry a unique product identifier encoded in a 2-D barcode. That identifier contains four data elements: the National Drug Code (NDC), a serial number unique to that specific package, a lot number, and an expiration date. The combination allows every unit to be distinguished from every other unit of the same drug.

Transaction documentation must accompany each transfer of ownership. The three required documents are the Transaction Information (TI), Transaction History (TH), and Transaction Statement (TS)—sometimes called the T3. Pharmacies must receive and store these documents and must be able to produce them on request.

Verification is required when a product is flagged as suspect or illegitimate. A product is considered suspect when its condition, packaging, or documentation raises a question about authenticity or integrity—for example, a package whose barcode does not resolve to a known NDC, or a product received with no accompanying transaction documents.

Handling Suspect and Illegitimate Products

If you scan an incoming package and the serialized identifier does not verify, or if the packaging looks tampered with, you must quarantine the product immediately and notify the pharmacist-in-charge. The pharmacist will initiate the DSCSA verification process with the trading partner. If a product is confirmed illegitimate, the pharmacy must notify the FDA and the immediate trading partner within a specified timeframe under DSCSA requirements. Do not dispense any product that has been identified or is suspected as illegitimate.

Safety Priorities

Patient safety is the reason these systems exist. A Class I recalled product on your shelf is a direct threat to the next patient who might receive it. A counterfeit product with incorrect active ingredient or potency can cause treatment failure or overdose. Your role is to act, document, and escalate—not to independently decide whether a recall or a suspect-product flag is serious enough to act on. When in doubt, quarantine and ask the pharmacist.

Always verify lot numbers character by character against the recall notice. Lot numbers that differ by a single digit are not the same lot. Likewise, when scanning serialized products, trust the system result—do not override a failed scan without pharmacist authorization.

Key terms9

Class I RecallThe most serious FDA recall classification, issued when a product is reasonably likely to cause serious adverse health consequences or death; requires immediate removal from dispensing.
Class II RecallAn FDA recall classification for products that may cause temporary or reversible adverse health consequences, or where the probability of serious harm is remote.
Class III RecallThe least severe FDA recall classification, issued when a product is unlikely to cause adverse health consequences but violates FDA regulations or labeling requirements.
Drug Supply Chain Security Act (DSCSA)Federal law establishing an electronic, interoperable system to identify, trace, and verify prescription drug products throughout the supply chain to prevent counterfeit or illegitimate drugs from reaching patients.
Product SerializationThe requirement that every prescription drug package carry a unique product identifier—encoded in a 2-D barcode—containing the NDC, a serial number, lot number, and expiration date.
Transaction Information, History, and Statement (T3)The three DSCSA-required documents that must accompany each ownership transfer of a prescription drug product, enabling full traceability through the supply chain.
Suspect ProductUnder DSCSA, a prescription drug product whose integrity or authenticity cannot be confirmed because of questionable condition, packaging, documentation, or a failed serialization verification.
QuarantineThe practice of physically separating a recalled, suspect, or illegitimate product from dispensing inventory and clearly labeling it to prevent accidental dispensing.
Lot NumberA manufacturer-assigned alphanumeric code identifying a specific batch of drug product; used to precisely identify which units are affected by a recall.
In class: Recall pull exercise · Serialised-product scan · Suspect-product scenario
Materials: Recall notices, serialised packages
Check: Recall drill: competent

Practice check8

Answer each question, then check it. Nothing is recorded; this is your own practice.

Federal Requirements
1. A pharmacy receives a recall notice for a blood-pressure medication stating the product 'is reasonably likely to cause serious adverse health consequences or death.' Which recall class does this describe?
Patient Safety and Quality Assurance
2. After receiving a Class I recall notice, a pharmacy technician confirms two bottles of the recalled lot are in stock. What is the correct immediate action?
Patient Safety and Quality Assurance
3. When searching for recalled product, a technician checks the shelf but not the automated dispensing cabinet or will-call bin. Why is this approach inadequate?
Federal Requirements
4. Under the Drug Supply Chain Security Act, which four data elements must appear in the unique product identifier on every prescription drug package?
Federal Requirements
5. A technician scans an incoming shipment and the 2-D barcode on one package fails to resolve to a known NDC. According to DSCSA procedures, what should the technician do?
Federal Requirements
6. The three documents collectively required under DSCSA to accompany each transfer of ownership of a prescription drug are known as:
Patient Safety and Quality Assurance
7. A Class III recall notice arrives for a cough syrup. The technician says, 'This is the lowest class, so we don't need to pull it.' Which statement best explains why this reasoning is wrong?
Federal Requirements
8. A pharmacy confirms that a received product is illegitimate under DSCSA. Beyond quarantining the product, which parties must be notified?
Record this lesson on my transcript. Sign in with your key and enrollment email to record lessons (enroll free if you have no key). This page stays open to read and practise.
← Previous lessonTop-200 drugsNext lesson →